TFF PHARMACEUTICALS, INC. Research and Development Expense
TFF PHARMACEUTICALS, INC. reported Research and Development Expense of $1.69 million for the 3-month period ending 2024-09-30, per its 10-Q filed 2024-11-20.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:ResearchAndDevelopmentExpense · last filed 2024-11-20
- TFF PHARMACEUTICALS, INC. research and development expense for the quarter ending 2024-09-30 was $1.69M, a 29.00% decline year-over-year.
- TFF PHARMACEUTICALS, INC. research and development expense for the quarter ending 2024-06-30 was $2.59M, a 3.49% decline year-over-year.
- TFF PHARMACEUTICALS, INC. research and development expense for the quarter ending 2024-03-31 was $3.56M, a 11.52% decline year-over-year.
- TFF PHARMACEUTICALS, INC. research and development expense for the quarter ending 2023-12-31 was $2.97M, a 28.09% decline year-over-year.
- TFF PHARMACEUTICALS, INC. research and development expense for fiscal 2023 was $12.06M, a 34.79% decline from fiscal 2022.
- TFF PHARMACEUTICALS, INC. research and development expense for fiscal 2022 was $18.50M, a 13.17% decline from fiscal 2021.
- TFF PHARMACEUTICALS, INC. research and development expense for fiscal 2021 was $21.30M, a 99.42% increase from fiscal 2020.
- TFF PHARMACEUTICALS, INC. research and development expense for fiscal 2020 was $10.68M, a 21.08% increase from fiscal 2019.
| Period end | Research and Development Expense 1 month | Research and Development Expense 1 month as first filed | Research and Development Expense 3 month | Research and Development Expense 3 month as first filed | Research and Development Expense 6 month | Research and Development Expense 6 month as first filed | Research and Development Expense 8 month | Research and Development Expense 9 month | Research and Development Expense 11 month | Research and Development Expense 12 month |
|---|---|---|---|---|---|---|---|---|---|---|
| 2024-09-30 | $1.69M 10-Q · filed 2024-11-20 | $4.28M derived: sum of 2 quarters · filed 2024-11-20 | $7.84M 10-Q · filed 2024-11-20 | $10.81M derived: sum of 4 quarters · filed 2024-11-20 | ||||||
| 2024-06-30 | $2.59M 10-Q · filed 2024-08-14 | $6.14M 10-Q · filed 2024-08-14 | $9.12M derived: sum of 3 quarters · filed 2024-08-14 | $11.51M derived: sum of 4 quarters · filed 2024-11-20 | ||||||
| 2024-03-31 | $3.56M 10-Q · filed 2024-05-14 | $6.53M derived: sum of 2 quarters · filed 2024-05-14 | $8.92M derived: sum of 3 quarters · filed 2024-11-20 | $11.60M derived: sum of 4 quarters · filed 2024-11-20 | ||||||
| 2023-12-31 | $2.97M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-28 | $5.36M derived: sum of 2 quarters · filed 2024-11-20 | $8.04M derived: sum of 3 quarters · filed 2024-11-20 | $12.06M 10-K · filed 2024-03-28 | ||||||
| 2023-09-30 | $2.39M 10-Q · filed 2024-11-20 | $5.07M derived: sum of 2 quarters · filed 2024-11-20 | $9.09M 10-Q · filed 2024-11-20 | $13.22M derived: sum of 4 quarters · filed 2024-11-20 | ||||||
| 2023-06-30 | $2.68M 10-Q · filed 2024-08-14 | $6.70M 10-Q · filed 2024-08-14 | $10.84M derived: sum of 3 quarters · filed 2024-08-14 | $14.86M derived: sum of 4 quarters · filed 2024-08-14 | ||||||
| 2023-03-31 | $4.02M 10-Q · filed 2024-05-14 | $24.91K 10-Q · filed 2023-05-11 | $8.15M derived: sum of 2 quarters · filed 2024-05-14 | $12.18M derived: sum of 3 quarters · filed 2024-05-14 | $17.28M derived: sum of 4 quarters · filed 2024-05-14 | |||||
| 2022-12-31 | $4.14M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-28 | $8.16M derived: sum of 2 quarters · filed 2024-03-28 | $13.26M derived: sum of 3 quarters · filed 2024-03-28 | $18.50M 10-K · filed 2024-03-28 | ||||||
| 2022-09-30 | $4.03M 10-Q · filed 2023-11-14 | $9.13M derived: sum of 2 quarters · filed 2023-11-14 | $14.36M 10-Q · filed 2023-11-14 | $21.31M derived: sum of 4 quarters · filed 2023-11-14 | ||||||
| 2022-06-30 | $5.10M 10-Q · filed 2023-08-14 | $5.11M 10-Q · filed 2022-08-11 | $10.34M 10-Q · filed 2023-08-14 | $10.37M 10-Q · filed 2022-08-11 | $17.28M derived: sum of 3 quarters · filed 2023-08-14 | $23.62M derived: sum of 4 quarters · filed 2023-08-14 | ||||
| 2022-03-31 | $5.26M 10-Q · filed 2022-05-11 | $12.18M derived: sum of 2 quarters · filed 2023-03-31 | $18.52M derived: sum of 3 quarters · filed 2023-03-31 | $21.28M derived: sum of 4 quarters · filed 2023-03-31 | ||||||
| 2021-12-31 | $6.92M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-31 | $13.26M derived: sum of 2 quarters · filed 2023-03-31 | $16.02M derived: sum of 3 quarters · filed 2023-03-31 | $21.30M 10-K · filed 2023-03-31 | ||||||
| 2021-09-30 | $6.34M 10-Q · filed 2022-11-14 | $9.10M derived: sum of 2 quarters · filed 2022-11-14 | $14.38M 10-Q · filed 2022-11-14 | $17.43M derived: sum of 4 quarters · filed 2022-11-14 | ||||||
| 2021-06-30 | $2.76M 10-Q · filed 2022-08-11 | $8.04M 10-Q · filed 2022-08-11 | $11.10M derived: sum of 3 quarters · filed 2022-08-11 | $13.92M derived: sum of 4 quarters · filed 2022-08-11 | ||||||
| 2021-03-31 | $5.28M 10-Q · filed 2022-05-11 | $8.33M derived: sum of 2 quarters · filed 2022-05-11 | $11.16M derived: sum of 3 quarters · filed 2022-05-11 | $13.72M derived: sum of 4 quarters · filed 2022-05-11 | ||||||
| 2020-12-31 | $3.05M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-24 | $5.88M derived: sum of 2 quarters · filed 2022-03-24 | $8.45M derived: sum of 3 quarters · filed 2022-03-24 | $10.68M 10-K · filed 2022-03-24 | ||||||
| 2020-09-30 | $2.82M 10-Q · filed 2021-11-15 | $5.39M derived: sum of 2 quarters · filed 2021-11-15 | $7.63M 10-Q · filed 2021-11-15 | $10.90M derived: sum of 4 quarters · filed 2021-11-15 | ||||||
| 2020-06-30 | $2.57M 10-Q · filed 2021-08-12 | $4.80M 10-Q · filed 2021-08-12 | $8.07M derived: sum of 3 quarters · filed 2021-08-12 | $10.64M derived: sum of 4 quarters · filed 2021-08-12 | ||||||
| 2020-03-31 | $2.24M 10-Q · filed 2021-05-13 | $5.50M derived: sum of 2 quarters · filed 2021-05-13 | $8.07M derived: sum of 3 quarters · filed 2021-05-13 | $9.39M derived: sum of 4 quarters · filed 2021-05-13 | ||||||
| 2020-01-31 | $909.40K 10-Q · filed 2020-08-13 | $546.17K 10-Q · filed 2020-05-14 | ||||||||
| 2019-12-31 | $1.13M 10-Q · filed 2020-08-13 | $3.27M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-10 | $5.83M derived: sum of 2 quarters · filed 2021-03-10 | $7.15M derived: sum of 3 quarters · filed 2021-03-10 | $8.82M 10-K · filed 2021-03-10 | |||||
| 2019-09-30 | $2.56M 10-Q · filed 2020-11-05 | $3.88M derived: sum of 2 quarters · filed 2020-11-05 | $5.55M 10-Q · filed 2020-11-05 | |||||||
| 2019-06-30 | $1.32M 10-Q · filed 2020-08-13 | $2.99M 10-Q · filed 2020-08-13 | ||||||||
| 2019-03-31 | $1.67M 10-Q · filed 2020-05-14 | |||||||||
| 2018-12-31 | $848.81K 10-K · filed 2020-03-27 | |||||||||
| 2018-09-30 | $140.17K 10-Q · filed 2019-12-09 | $759.36K 10-Q · filed 2019-12-09 |